Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients

Silvia Bellesi1, Elisabetta Metafuni1, Stefan Hohaus1,2

  • 1Dipartimento di Diagnostica per Immagini, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Radioterapia Oncologica ed Ematologia, Rome, Italy.

Insights

COVID-19 infection is associated with increased expression of CD95 and PD-1 on T cells, indicating potential T cell exhaustion and apoptosis. This immune response may contribute to disease severity and altered T cell counts in patients.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Low CD4+ and CD8+ T lymphocyte counts are characteristic of COVID-19.
  • T cell exhaustion and apoptosis are implicated in severe viral infections.

Purpose of the Study:

  • To investigate the expression of CD95 (Fas) and PD-1 on T cells in COVID-19 patients.
  • To correlate T cell marker expression with clinical parameters like lymphocyte counts.

Main Methods:

  • Flow cytometry was used to analyze T cell surface markers.
  • Comparison of marker expression between 42 COVID-19 patients and healthy controls.

Main Results:

  • Significantly higher CD95 and PD-1 expression on CD4+ and CD8+ T cells in COVID-19 patients.
  • Higher CD95 expression on CD4+ T cells correlated with lower CD4+ counts.
  • Increased CD95 expression on T cells correlated with a reduced percentage of naive T cells.

Conclusions:

  • COVID-19 infection induces T cell activation, characterized by increased expression of apoptosis- and exhaustion-related molecules.
  • These findings suggest a mechanism for T cell depletion and dysfunction during SARS-CoV-2 infection.